It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2021.
2021 | Mumbai, Maharashtra, India | ActiveAvsplus Pharma Private Limited, a active private limited company, was established on 11 March 2021 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2021PTC356814. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.27 M.
Its leadership includes Kalpesh Prakashchand Jain (Director), Yogendra Gangaram Mungale (Director), Deepesh Deepak Kolge (Director). Past directors included Mayur Mulchand Shah, Anagha Bipin Nachane, Urvashi Sharad Mistry. It holds ₹15.00 Cr open charges and ₹4.00 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 51, Manik Apartment Bhawani Shankar Road, Dadar West, Mumbai, Maharashtra, 400028.
U51909MH2021PTC356814
356814
11 March 2021
₹5.00 M
₹3.27 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Avsplus Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalpesh Prakashchand Jain | Director | 11 Mar 2021 | Current |
| Yogendra Gangaram Mungale | Director | 11 Mar 2021 | Current |
| Deepesh Deepak Kolge | Director | 21 Sep 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 May 2023 | Past |
| Pramod Abcsdd | Director | 10 May 2023 | Past |
| Pramod Abcsdd | Director | 11 Apr 2022 | Past |
| Pramod Abcsdd | Director | 09 May 2024 | Past |
| Pramod Abcsdd | Director | 09 May 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avsplus Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.21% increase. The company also saw a substantial fall in profitability, with a 26.9% decrease in profit. The company's net worth Soared by an impressive increase of 5533.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Avsplus Pharma had a promoter holding of 52.99% and a public holding of 47.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹150,000,000.00
₹40,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2023 | Others | ₹15.00 Cr | Open |
| 30 Nov 2021 | Others | ₹4.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Avsplus Pharma has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Avsplus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avsplus Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 30 Nov 2021 via Charge ID 100525013 with Others was fully satisfied on 20 Dec 2023. was completed.
Avsplus Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Avsplus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 150.00 M with Charge ID 100676727 was registered on 30 Jan 2023. was completed.
Deepesh Deepak Kolge was appointed as a Director was appointed as a Director on 21 Sep 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.
The activity A charge with Others amounted to Rs. 40.00 M with Charge ID 100525013 was registered on 30 Nov 2021. was completed.
The CIN of Avsplus Pharma Private Limited is U51909MH2021PTC356814.
Avsplus Pharma Private Limited is headquartered at 51, Manik Apartment Bhawani Shankar Road, Dadar West, Mumbai, Maharashtra, 400028.
Avsplus Pharma Private Limited was incorporated on 11 March 2021.
The current directors of Avsplus Pharma Private Limited are
The primary industry of Avsplus Pharma Private Limited is Trade.
Avsplus Pharma Private Limited is unlisted.
The authorized capital of Avsplus Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹3.27 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX